Frichti grabs €30 million and asserts itself as the French leader of foodtech

News

Frichti is raising a €30 million round with Verlinvest and Felix Capital alongside its existing investor Alven Capital and Idinvest Partner.

Frichti is now the most-funded food startup in France. Compared to other French food startups, the company revolutionizes the daily life of it’s customers by proposing fresh products, raw or cooked. Breakfast, lunch, snack, aperitif, dinner, brunch or shopping online, Frichti responds to every desire and every occasion in just 30 minutes at an affordable price.

Frichti tries to optimize its rides by handing out multiple deliveries : the algorithm  created internally makes it possible to group the delivery of neighboring commands.

Developed by a duo of passionate entrepreneurs, in only 23 months, Frichti  now has more than 300 employees and will begin to internationalize to share the French know-how.

We have been fortunate to accompany this exceptional team since the very first days of the Frichti adventure. The original vision of the founders has been growing and developing to provide consumers with an experience. This quality improvement was achieved in parallel with an extremely rapid growth of the activity, and it is this attention to detail and this respect for consumers coupled with a very strong ambition which will, we are sure, enable Frichti to continue to convince in France, and soon beyond our borders !


Share

Neural Concept raises its $100M Series C led by Goldman Sachs 

Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development raises a $100 million Series C funding…

Read

Altrove raises $10 million to turn AI-predicted materials into industrial reality

Paris-based AI startup creates homegrown, sustainable and safer alternatives to critical materials such as rare earths, reducing dependence on imports and strengthening…

Read

StratifAI Raises €12.5M for clinical Validation of AI BiomarkerPlatform Polaris™ for Precision Oncology

Oversubscribed round led by Picus Capital and Alven will fast-track clinical validation of AI-based Cancer- Biomarker Platform Polaris™, expand global reach, and…

Read